Delivery Order SPE2D021DA002-SPE2D325F307K
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 by the Defense Logistics Agency's Medical Supply Chain division for TWINRIX vaccine syringes. The award, issued on July 21, 2025, with an ultimate completion date of July 24, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1,636.62 to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe format. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and will be performed at the...
- The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $8,183.10 to DMS Pharmaceutical Group Inc. on August 1, 2025, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract carries no set-aside designation, allowing DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $95,392.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the TWINRIX VACCINE SYRINGE, with a completion date of June 14, 2024. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,808.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TWINRIX VACCINE SYRINGE and has an ultimate completion date of August 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The $1,602.92 contract is for the delivery of the TWINRIX VACCINE SYRINGE with a completion date of February 7, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract, SPE2DB, with the Defense Logistics Agency valued up to $4,999,999 through 2025 to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX VACCINE SYRINGE and has a completion date of June 21, 2024. DMS Pharmaceutical Group Inc. holds a separate, larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $13,627.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TWINRIX vaccine syringes and has a completion date of July 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) vehicle valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
- This federal contract award, valued at $1,602.92, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Twinrix vaccine syringes, with a period of performance through December 16, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F307KDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,454.93 on August 11, 2025, for the supply of Twinrix vaccine syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026, which authorizes the issuance of delivery orders for comprehensive pharmaceutical products supporting Department of Defense healthcare facilities nationwide. The delivery order fulfills medical supply needs for the Defense-affiliated Medical Supply Chain, with performance taking place at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company's extensive portfolio of federal contract awards demonstrates consistent capability in delivering branded and generic pharmaceutical products, biologics, vaccines, and medical consumables to military health facilities across the country.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/11/25 |